Blue Historical Income Statement
| 002382 Stock | 5.07 0.06 1.17% |
Historical analysis of Blue Sail income statement accounts such as Selling General Administrative of 251.1 M, Total Revenue of 5.9 B or Cost Of Revenue of 5.2 B can show how well Blue Sail Medical performed in making a profits. Evaluating Blue Sail income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Blue Sail's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Blue Sail Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Blue Sail Medical is a good buy for the upcoming year.
Blue |
About Blue Income Statement Analysis
Blue Sail Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Blue Sail shareholders. The income statement also shows Blue investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Blue Sail Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Blue Sail Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Cost Of Revenue
Cost of Revenue is found on Blue Sail Medical income statement and represents the costs associated with goods and services Blue Sail provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Blue Sail's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Blue Sail Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Blue Sail Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Blue Sail's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 5.9 B, whereas Selling General Administrative is forecasted to decline to about 251.1 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Gross Profit | 501.5M | 606.1M | 697.0M | 662.1M | Interest Income | 36.7M | 26.3M | 30.2M | 35.1M |
Blue Sail income statement Correlations
Click cells to compare fundamentals
Blue Sail Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Blue Sail income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 189.9M | 133.3M | 129.5M | 180.5M | 207.5M | 217.9M | |
| Selling General Administrative | 681.2M | 521.5M | 482.2M | 331.0M | 380.6M | 251.1M | |
| Total Revenue | 7.9B | 8.1B | 4.9B | 4.9B | 5.7B | 5.9B | |
| Operating Income | 4.1B | 2.6B | (526.7M) | (470.0M) | (540.5M) | (513.5M) | |
| Cost Of Revenue | 2.8B | 4.3B | 4.4B | 4.3B | 5.0B | 5.2B | |
| Income Before Tax | 2.0B | 1.3B | (405.9M) | (622.6M) | (716.0M) | (680.2M) | |
| Net Income Applicable To Common Shares | 490.3M | 1.8B | 1.2B | (372.3M) | (428.2M) | (406.8M) | |
| Net Income | 1.8B | 1.2B | (372.3M) | (568.4M) | (653.6M) | (620.9M) | |
| Income Tax Expense | 56.8M | 255.3M | 191.6M | (33.5M) | (38.6M) | (36.6M) | |
| Research Development | 291.4M | 438.5M | 352.5M | 290.8M | 334.4M | 201.7M | |
| Tax Provision | 255.3M | 191.6M | (33.5M) | (54.2M) | (48.8M) | (46.4M) | |
| Net Interest Income | (280.1M) | (81.1M) | (96.7M) | (158.1M) | (142.3M) | (149.4M) | |
| Interest Income | 64.0M | 56.7M | 36.7M | 26.3M | 30.2M | 35.1M | |
| Gross Profit | 5.1B | 3.8B | 501.5M | 606.1M | 697.0M | 662.1M | |
| Other Operating Expenses | 21.0M | 34.4M | 54.8M | 36.9M | 42.5M | 33.6M | |
| Net Income From Continuing Ops | 1.8B | 1.2B | (372.3M) | (568.4M) | (511.5M) | (485.9M) | |
| Ebit | 625.4M | 4.0B | 2.4B | (674.0M) | (775.1M) | (736.4M) | |
| Total Operating Expenses | 3.8B | 5.5B | 5.4B | 5.4B | 6.2B | 3.8B | |
| Minority Interest | 31.2M | 114.9K | 554.99 | 15.66 | 14.09 | 13.39 | |
| Ebitda | 876.3M | 2.4B | 1.8B | 212.6M | 244.5M | 232.3M | |
| Reconciled Depreciation | 213.7M | 332.2M | 489.0M | 524.5M | 603.2M | 303.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Blue Stock
Blue Sail Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Blue Sail shareholders. The income statement also shows Blue investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).